In the body, 5-fluorouracil is converted to its active metabolite 5-fluorodeoxyuridine monophosphate, which inhibits thymidylate synthase, hence the drug is widely used for treating colorectal, pancreatic, ovarian, breast, etc., cancer patients [52]. Here, TYMS is linked to cancer.